Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Orthex Corporation: Managers’ Transactions – Tom Ståhlberg

Orthex Corporation, Managers’ Transactions, 28 March 2024 at 1.00 p.m. EET_______________________________________Person subject to the notification requirementName: Tom StåhlbergPosition: Other senior managerIssuer: Orthex CorporationLEI: 7437008RMK8BSWN39T09Notification type: INITIAL NOTIFICATION_______________________________________Transaction date: 2024-03-27Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000480504Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 222 Unit price: 6.09000 EUR(2): Volume: 278 Unit price: 6.

Independent Monitor certifies Ericsson’s Compliance Program

Ericsson (NASDAQ: ERIC) today announced that on March 28, 2024, the independent compliance Monitor appointed by the U.S. Department of Justice (DOJ) (in June of 2020 in connection with Ericsson’s resolution of historical violations of the Foreign Corrupt Practices Act (FCPA) violations) has certified that Ericsson's anti-corruption compliance program has satisfied requirements and is functioning effectively. This independent certification is a condition to conclusion of the Monitorship and Plea Agreement, currently expected to occur no later than June 2, 2024.Ericsson’s Chair of the Board

BioStock: Cyxone comments on the clinical collaboration in the UK

Cyxone has entered into a research collaboration with a renowned British research group in Glasgow with the aim of conducting an exploratory phase II study with rabeximod in rheumatoid arthritis patients. BioStock reached out to CEO Carl-Magnus Högerkorp, who highlights the research group’s collaboration with the universities of Birmingham, Newcastle, and Oxford in the field.Read the full interview with Carl-Magnus Högerkorp at biostock.se: https://www.biostock.se/en/2024/03/cyxone-comments-on-the-clinical-collaboration-in-the-uk/ This is a press release from BioStock - Connecting

An additional five days for the annual outage of Olkiluoto 3

The first outage of Olkiluoto 3 will be extended by five days and will end on April 20. The fuel checks of the plant unit require more time than planned.Previously, we reported on the cooling of the components slower than expected and some technical problems that caused a one-week extension to the annual maintenance. Now the five-day additional time is needed especially for extra fuel checks. When the fuel is transferred back to the reactor at the end of the annual outage, we want to ensure their cleanliness so that no loose parts get into the process.  The annual outage of OL3 started

Beijer Ref’s annual report and sustainability report 2023

Beijer Ref's annual report and sustainability report for 2023 is now available for download on Beijer Ref's website www.beijerref.com. Printed copies of the annual report can be ordered at the following email: api@beijerref.com Malmö, 28 March 2024Beijer Ref AB (publ) For more information, please contact: Joel DavidssonCFOTelephone: +46 40-35 89 00Email: jdn@beijerref.com Niklas WillstrandDirector of Global CommunicationsTelephone: +46 40-35 89 00Email: nwd@beijerref.com BEIJER REF AB is a technology-oriented trading Group which, through added-value products,

Diamyd Medical publishes prospectus with regards to the rights issue

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONGKONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SWITZERLAND, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTION IN WHOLE OR IN PART, IS SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN DIAMYD MEDICAL AB IN ANY JURISDICTION. PLEASE REFER TO THE “IMPORTANT INFORMATION” SECTION BELOW. The prospectus with regards to Diamyd Medical AB’

Qlife announces the last day for trading in BTU and the first day for trading in warrants series TO 4 and TO 5

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASUREThe rights issue of units that was announced on 12 December 2023 (the “Rights Issue”) in Qlife Holding AB (“Qlife” or the “Company”) has been registered with the Swedish Companies Registration Office (Sw. Bolagsverket) and paid

Gradientech unveals European clinical study data

The diagnostics company Gradientech today announces the publication of data from the large multicenter clinical study of the QuickMIC® system in collaboration with leading European hospitals. QuickMIC is the today fastest diagnostic system on the market for antibiotic susceptibility testing (AST) of sepsis samples.Clinical study data from the multicenter performance evaluation of the QuickMIC system shows that QuickMIC is highly accurate compared to the reference testing method for AST, broth microdilution. QuickMIC provides 95.6% agreement with the reference MIC values (Minimum Inhibitory

Peab builds bridge in Härnösand

Peab has been commissioned to tear down the existing bridge over Nattviken in central Härnösand and build an openable bridge in the same place. The customer is Härnösand Municipality and the contract is worth SEK 247 million.The current clapboard bridge was inaugurated in 1937 and has now come to the end of its technical life. The new bridge will be an arch bridge and is inspired by the very first bridge built there at the end of the 1800s. The new bridge will also have a swing section in the middle to let boat traffic through. While the bridge is being built Peab will build a temporary

Paindrainer AB announces novel partnership with esteemed Bragée Clinics to enhance remote patient care through patient-centric digital pain management programs

MEDICON VILLAGE, LUND, SWEDEN – Under a new partnership, Paindrainer AB, a pioneer in the field of digital healthcare technology and the well-established Bragée Clinics will conduct a commercial pilot aimed at strengthening pain management programs for remote chronic pain rehabilitation and treatment programs.Paindrainer offers an advanced digital solution in Paindrainer® Care Portal and evidence based Paindrainer® PD1 mobile application for health care professionals to remotely monitor their patients’ progress and improve their quality of life. Bragée Clinics is a premier clinic

Political strike in Finland to continue – the total impact of the four weeks’ strike on Outokumpu's adjusted EBITDA approximately EUR 80 million

Outokumpu OyjPress releaseMarch 28, 2024 at 12.00 noon EETPolitical strike in Finland to continue – the total impact of the four weeks’ strike on Outokumpu's adjusted EBITDA approximately EUR 80 million Political strikes in Finland have now been announced to continue for a fourth week until April 7, 2024. The estimated negative impact of this additional week on Outokumpu's adjusted EBITDA is approximately EUR 15 million, as we were now able to soften the cumulative impact. Thus, the total negative impact of the four-week political strike on Outokumpu’s adjusted EBITDA is

Conversion of shares in NCC AB, March 2024

According to NCC’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During March 2024, 9,073 Series A shares were converted to Series B shares at the request of shareholders, following which the total number of voting rights in the company amounts to 161,193,894. The total number of registered shares in the company amount to 99,760,956 of which 6,825,882 are Series A and 92 935 074 are Series B. NCC holds 2,099,221 Series B shares in treasury.

Synsam Group’s Annual and Sustainability Report for 2023 is published

The Annual Report and the Sustainability Report of Synsam AB (publ) for 2023 is now available on Synsam Group’s website: https://www.synsamgroup.com/en/investor-relations/reports-and-presentations/ The full report is primarily designed for reading on screens. There is a limited edition of printed copies which can be ordered via telephone +46 (0)8 619 28 60. For further information, please contact:Per Hedblom, Chief Financial Officer Synsam AB (publ)E-mail: per.hedblom@synsam.comTelephone: +46 8-619 28 60Website: www.synsamgroup.com This disclosure contains information that

Change in the total number of shares and votes in Sivers Semiconductors AB

The number of shares in Sivers Semiconductors AB (the "Company") as of 28 March 2024 amounts to 234,649,894 shares, of which all shares are ordinary shares. There are currently no issued shares of series C. The total number of votes in the Company as of 28 March 2024 amounts to 234,649,894.The change in the number of shares and votes in the Company is due to the conversion of 1,100,000 shares of series C into 1,100,000 ordinary shares. For more information, please contact:Anders Storm, CEOTel: +46 (0)70 262 6390Email: anders.storm@sivers-semiconductors.com The information is

Chosa Oncology – Appoints Chief Commercial Officer and new Chief Financial Officer

28 March 2024 CHOSA Oncology – today announced the appointment of Claus Frisenberg Pedersen as Chief Commercial Officer and Gerton Jönsson as the new Chief Financial OfficerAs part of CHOSA’s enforced focus on Business Development Claus Frisenberg Pedersen will dedicate his full attention to business development in CHOSA. Consequently, Gerton Jönsson has been appointed as the new CFO and will start right away. Gerton has more than 20 years of experience in financial management, including CFO experience with listed companies within the life science sector.   Peter Buhl Jensen,

Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares

(Stockholm, Sweden, March 28, 2024) - Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that as of March 28, 2024, the total number of issued shares of common stock is 86,126,221 of which 81,373,679 shares are outstanding.Autoliv retired 1,370,057 shares of common stock that had been repurchased during the quarter which resulted in a decrease in the issued shares. The Company now has a total of 86,126,221 issued shares of common stock of which 81,373,679 shares are outstanding. Each share of outstanding common stock is entitled

The lifecycle carbon footprint of the electricity production at Olkiluoto is low

The electricity produced in Olkiluoto is demonstrably very climate-friendly, with the calculated combined lifecycle footprint of the electricity produced at the three plant units only 9.1 g CO\2\e/kWh. That is less than one tenth of the 100 g CO\2\e/kWh* threshold value defined for climate-friendliness.The calculation of the carbon footprint covers the entire life cycle of nuclear power from uranium mining to the final disposal of spent nuclear fuel and the decommissioning of plant units. If the transmission of electricity, i.e., the Finnish national grid, is also included, the carbon

Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES(1a). Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: SVM UK Emerging Fund   (1b). Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer: ( )   (2). Reason for the notification (please mark the appropriate box or boxes with an “X”) An acquisition or disposal of voting rights: (X) An acquisition or disposal of financial instruments: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify):

Offer Declared Unconditional, Extended to April 10

White Pearl Technology Group (WPTG) yesterday released information that the public offer for Ayima Group has been declared unconditional with approximately 86% acceptance and all conditions of the offer being met or waived. The new share issue will commence around April 5. The offer has now also been extended until April 10 to allow time for the acceptance rate to reach over 90%. WPTG stated in a Press release that "White Pearl intends to call for redemption in accordance with the Companies Act in order to acquire the shares that were not submitted in the Offer. In connection thereto,

Lantmännen's Patrik Myrelid spoke about strengthened food preparedness at an information meeting in the Swedish Parliament

Lantmännen's Head of Strategy, Patrik Myrelid, was invited as a speaker at the information meeting about the current government investigation "Food preparedness for a new era" (”Livsmedelsberedskap för en ny tid”). Hushållningssällskapet was the organiser and the meeting was opened by Ingrid Petersson, an investigator for the government inquiry. The inquiry proposes, among other things, that the state should create emergency stocks of grain and agricultural inputs with the aim of increasing society's resilience and room for maneuver in the event of a crisis or war. Mikael Oscarsson (KD)

Camurus Annual Report for 2023

Lund, Sweden — 28 March 2024 — Camurus (CAMX) today announces that the Annual Report for 2023 now is available at the company’s website: www.camurus.com, and as an attachment to this press release. The Swedish version of the Annual Report is also available on the website in European Single Electronic Format (ESEF). The Annual Report also includes Camurus’ sustainability report. Fredrik Tiberg, President and CEO:“Camurus performed strongly during the year towards our vision of becoming a global, long-term sustainable, specialty pharmaceutical company focused on the development of

Invitation: Presentation of Sandvik’s report of the first quarter 2024

Sandvik will publish its first quarter results on Monday, April 22, 2024, at approximately 11:30 AM CEST. A combined webcast and conference call for investors, analysts and financial media will be held at 1:00 PM CEST. The report will be presented by Stefan Widing, President and CEO as well as by Cecilia Felton, CFO. The presentation will be broadcasted live on our website home.sandvik Dial-in details for the conference call: SE: +46 (0) 8 505 100 31 UK: +44 (0) 207 107 06 13 US: +1 (1) 631 570 56 13 From about 12:30 PM CEST presentation slides will be available on our

Alfa Laval’s annual and sustainability report for 2023 published

Alfa Laval’s annual and sustainability report for 2023 has today been published and can be downloaded from the Group’s website .  It is also attached to this press release.This is Alfa Laval   The ability to make the most of what we have is more important than ever. Together with our customers, we’re innovating the industries that society depends on and creating lasting positive impact. We’re set on helping billions of people to get the energy, food, and clean water they need.  And, at the same time, we’re decarbonising

There are no items matching the current filter
There are no more items matching the current filter
Back to top